THE HEALTH CELL: Rise of AI in Clinical Trials Luncheon
–
August 25, 2022
—ATTEND IN PERSON— New drug development is a huge endeavor that can take 15 years, cost > $2B and still have a 80 – 90% failure rate. Now new applications of AI may streamline this process by predictive modeling that increases drug safety, decreases development cost and time to market, and improves overall patient outcomes.